Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Redeeming credit card points can be tricky. Discover what to avoid to ensure you make the most out of your rewards and benefits.
19,119 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Bitcoin slides to $62K as the broader market weakens, but long bets rise in response, complicating the bitcoin price ...
Two popular ETFs divide energy exposure: XOP tracks producers, while OIH tracks oil services. This piece breaks down ...
A mega-merger and rising AI-powered data-center demand are changing how U.S. electric utilities operate. The shift is...
A growing number of Americans are eyeing early retirement in The Villages, Florida, with a $3,000 monthly budget if t...
As market volatility sinks into a familiar pattern, insiders are quietly loading up on beaten-down stock wall street ...
A CNBC analyst contends the FedEx selloff reflects misinterpretation of the income statement, not a collapse in deman...
Investors are watching FIGS as the stock shows signs of momentum. This article breaks down the reasons behind figs st...
The AI boom has put semiconductors in the spotlight. This guide breaks down the AMD vs Intel debate, offering a clear...
Intel and TSMC reported divergent earnings trajectories as AI demand reshapes chips. This analysis weighs growth, mar...
Lucid's stock sits near a critical pricing zone as its balance sheet frays and dilution fears mount, even as producti...
The dollar surged to year-to-date highs as five main factors push the currency higher, signaling broader market momen...